Menu

Research projects

Current research projects

Names marked by * and * indicate PhD student and PhD students in spe, respectively; names marked by § and § indicate present and future PostDocs.Cancer

  • FDG-PET/CT in patients with gliomas. Depts. of Neurology, Nuclear Medicine and Neurology. Odense University Hospitals. Started 2012. Jens Ole Jarden, Peter Grupe, Bjarne Winther Kristensen et al.
  • Up-front FDG-PET/CT in suspected head and neck cancer. Depts. of Ear-Nose-Throat Surgery, Nuclear Medicine and Pathology. Odense University Hospital. Starts April 2013. Max Ramsussen*, Christian Godballe, Anne Lerberg*, Poul F. Høilund-Carlsen et al.
  • FDG-PET/CT imaging in thyroid cancer. Depts. of Oncology, Ear-Nose-Throat Surgery, Nuclear Medicine and Pathology. Odense University Hospitals. Starts April 2013. Jeppe K. Lauridsen*, Lars Bastholt, Jørgen Johansen, Peter Grupe, Poul-Erik Braad, Poul F. Høilund-Carlsen et al.
  • "124I -Positron Emission Tomography before and during therapy for identification, dosimetry and staging in patients who have well-differentiated thyroid cancer." Depts. of Oncology, Ear-Nose-Throat Surgery, Nuclear Medicine and Pathology. Odense University Hospitals. Starts April 2013. Poul-Erik Braad*, Jørgen Johansen, Peter Grupe, Lars Bastholt, Lars Bastholt, Poul F. Høilund-Carlsen et al.
  • BREAC-AUT (Dual time FDG-PET/CT in suspected recurrant breast cancer). Depts. of Nuclear Medicine, Oncology, Plastic Surgery and Pathology, Odense University Hospital. Started 2012, ends 2014. Malene Hildebrandt§, Kirsten Falch, Christina Baun, Pathologist, Katrine Søe, Marianne Ewertz, Björn Blomberg*, Abass Alavi, Poul F. Høilund-Carlsen et al.
  • DILUCE (Dual PET/CT Imaging in Lung Cancer). Depts. of Nuclear Medicine, Lung Medicine, Thoracic Surgery and Pathology, Odense University Hospital. Started 2013, ends 2014. Mie Holm Vilstrup*, Niels Chr. Hansen, Peter Licht, Karen Ege, Björn Blomberg*, Abass Alavi, Poul F. Høilund-Carlsen et al.
  • EUFURO (Endoscopic Ultrasound (EUS) and PET-CT based follow-up of patients radically resected for cancer of the oesophagus, stomach or pancreas). Ole Steen Bjerring*, Michael Bau Mortensen, Henrik Petersen, Poul F. Høilund-Carlsen, et a. Started 2011, ends 2014.
  • PETOvaC (PET Estimation of Operability of Ovarian Cancer). Mie Holm Vilstrup*, Kirsten Jochumsen, Ole Mogensen, Oke Gerke, Pathologist, Poul F. Høilund-Carlsen et al. Starts 2013, ends 2015.
  • Prostate – Several projects on preoperative lymph node staging and bone metastases using FDG, F-choline, FACBC, MeAIB. Mads Hvid Poulsen*, Jørn Skibsted Jacobsen, Mike Mortensen*, Lars Lund, Niels Marcussen, Poul F. Høilund-Carlsen, et al. Starts again 2013, ends 20XX.
  • Neuroendocrine tumours, diagnosis and radioisotope therapy.
  • DLG-PET: Prospective national multicenter study with experimental PET / CT after first and 2 series immuno-chemotherapy in the primary treatment of diffuse large B-cell lymphoma. Evaluates "timing" of the metabolic response evaluation by current standard methods (visual semiquantitative and SUVmax). Karen Juul Mylam*, Lars Møller Pedersen, Henrik Petersen, Anne Lerberg, Oke Gerke, Abass Alavi, Poul F. Høilund-Carlsen et al. Started 2012, ends 2014.
  • Triple PET in lymphomas. DLBCL, FL and HL, 10 patients in each group. Triple time point PET pretherapy and after 3 or 4 cycles of R-CHOP like therapy. Tissue smear for the immunohistochemical evaluation. Karen Juul Mylam*, Lars Møller Pedersen, Henrik Petersen, Anne Lerberg, Oke Gerke, Abass Alavi, Poul F. Høilund-Carlsen et al. Started 2012, ends 2014.
  • FULIMA (Functional Imaging In Multiple Myeloma). Dual time FDG-PET/CT and diffusion weighed MRI in multiple myoloma. Brian Østergaard*, Niels Abildgaard, Henrik Petersen, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 2014.
  • CUP (Cancer of Unknown Primary). Sys Vestergaard, Charlotte Rask, Karen Kjær Pedersen, Iben Fasterholdt, Annemarie Touborg Lassen, Poul F. Høilund-Carlsen et al. Starts 2011, ends 20XX.
  • BoneMets: FDG-, NaF-,F-choline-PET/CT vs wholebody SPECT bone scans and diffusion weighted MRI in bone metastases from prostate and breast cancer. Søren Hess*, Mads Hvid Poulsen, Lars Lund, Malene Hildebrandt, Marianne Ewerts, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2013, ends 2015.

Arteriosclerosis

  • CAMONA: Cardiovascular Molecular Calcification Assessed by 18F-NaF PET/CT and FDG-PET/CT – in the heart, the carotid arteries and the aorta. Björn Blomberg, Axel Diederichsen, Anders Thomassen, Peter Grupe, Jane Simonsen, Malene Hildebrandt, Søren Hess, Allan Johansen, Henrik Petersen, Oke Gerke, Michael Hecht Olsen, Kim Brixen, Werner Vach, Hans Mickley, Abass Alavi, Poul F. Høilund-Carlsen. Running, first part ends 2012, follow-up ends 2014.
  • SOFIA: Sodium Fluoride and Fluorodeoxyglucose Avidity in Carotid Atheroma: Histopathological Correlates. Björn A. Blomberg, Poul F. Høilund-Carlsen, Jess S. Lindholt, Oke Gerke, Birgitte B. Olsen, Bjarne Winther Kristensen, Peter Grupe, Abass Alavi. Starts 2012, ends 2014.
  • CARAT: Coronary Calcification after Radiation Therapy of Breast Cancer – assessed by CT and NaF-PET/CT. Malene Grubbe Hildebrandt§, Henrik Petersen, Allan Johansen, Oke Gerke, Poul-Erik Braad, Poul F. Høilund-Carlsen, Marianne Ewertz, Axel Diederichsen, Hans Mickley, Sarah Darby, Werner Vach, Abass Alavi.
  • PAAR: Predicition of Abdominal Aortic Rupture by PET/CT. Jes Lindholdt et al.
  • DIPARD: Diabetic Peripheral Arterial Disease evaluated by CT and NaF-PET/CT. Willem Mali et al.

Infection/inflammation

  • DVT/PE: Deep Vein Thrombosis and Pulmonary Embolism Assessed by FDG-PET/CT. Søren Hess*, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2013, ends 2015.
  • IBD-Children: Accuracy of PET/CT in Diagnosis and Treatment Evaluation of Children and Adolescents with Inflammatory Bowel Disease. Mikkel Malham*, Rasmus Gaardskær Nielsen, Klaus Johansen, Eva Kiib, Kirsten Larsen, Poul F. Høilund-Carlsen, Søren Hess, Uffe Holmskov, Steffen Husby et al. Starts 2012, ends 2014.
  • PSORIPET: FDG-PET/CT in Psoriasis. Kristina Lings*, Björn Blomberg, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 2014.
  • ALLOPET: Alloplasty Infection Assesse by PET/CT. Søren Overgaard, Søren Hess, Henrik Petersen, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 20XX.

Musculoskeletal system

  • OSTEOPOROSIS: Assessment of bone density by NaF-PET/CT. Björn Blomberg, Kim Brixen, Poul F. Høilund-Carlsen et al. Starts 2012, ends 2014.
  • ALUET: Assessment of lumbar fusion by 18F-sodium fluoride positron emission tomography/computed tomography. Michael Kjær Jakobsen*, Carsten Ernst, Mikkel Andersen,
  • Annette Bennedsgaard Jespersen, Henrik Petersen, Oke Gerke, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 2014.
  • PTH-DESE: Randomized study of placebo vs PTH hormone for stimulation of bone healing following lumbar athrodesis operation. Annette Bennedsgaard Jespersen*, Michael Kjær Jakobsen, Carsten Ernst, Mikkel Andersen, Henrik Petersen, Oke Gerke, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 2014.
  • ABACK: Acute Back Pain Assessed by lumbar NaF-PET/CT and cerebral FDG-PET/CT. Janne Rasmussen*, Mikkel Østerheden Andersen, Henrik Petersen, Abass Alavi, Poul F. Høilund-Carlsen et al. Starts 2012, ends 20XX.

Translational

  • Allergy: Carsten Bindslev-Jensen
  • Arterial hypertension: Michael Hect Olsen, Marie Kofoed Blicher, Jens Chr. Gam
  • Cancer cell biology: Jan Mollenhauer
  • Cell biology: Birgitte B. Olsen
  • 3D-dosimetry: Jørgen Johansen
  • Genetic profiling: Torben Kruse, Mads Thomassen,
  • Immunohistochemistry: Bjarne W. Kristensen
  • Nucleac acid chemistry: Jesper Wengel, Stefan Vogel
  • Renal Blood Flow: Peter Bie, Mads Damkjær, Jens Chr. Gam
  • Small animal imaging: Søren Schifter, Torben Uhrenholdt, Peter Bollen
  • Biostastistics: Oke Gerke, Werner Vach

Radiochemistry & Nuclear Physics

  • Health economy: Kristian Kidholm, Iben Fasterholt
  • [ 11C] -& [ 15F] -tracers: Kjell Någren
  • Special tracers: Bengt Långström
  • New platforms: Bengt Långström
  • Auger-emitters: Helge Thisgaard

To give you the best possible experience, this site uses cookies Read more about cookies

Accept cookies